Differential effect of humoral endorphin on the binding of opiate agonists and antagonists

Eur J Pharmacol. 1982 Jul 9;81(2):227-35. doi: 10.1016/0014-2999(82)90440-x.

Abstract

Humoral (H) endorphin, a novel endogenous factor with opiate-like activity was further characterized using various radioreceptor assays. H-Endorphin displaced both labelled opiates (morphine, ethylketazocine) and opioid peptides (leucine-enkephalin) from their specific binding sites in rat brain membranes. The effect of sodium ions on H-endorphin indicates its agonistic nature which is in agreement with previous pharmacological experiments. However, H-endorphin potentiated the binding of the opiate antagonist naloxone to brain membranes. This peculiar effect of H-endorphin on naloxone, together with the non-conventional interactions observed in various pharmacological assays, clearly distinguishes H-endorphin from other opioid ligands. A multisite model of the opiate receptor is presented. This model, which is compatible with the well documented evidence for receptors heterogeneity also explains non-conventional interactions between various opioid ligands.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Binding, Competitive
  • Cyclazocine / analogs & derivatives
  • Cyclazocine / metabolism
  • Endorphins / pharmacology*
  • Enkephalins / metabolism
  • Ethylketocyclazocine
  • In Vitro Techniques
  • Male
  • Morphine / metabolism
  • Naloxone / metabolism
  • Narcotic Antagonists / metabolism*
  • Narcotics / metabolism*
  • Quinuclidinyl Benzilate / metabolism
  • Radioligand Assay
  • Rats
  • Receptors, Opioid / drug effects
  • Receptors, Opioid / metabolism*
  • Sodium / pharmacology

Substances

  • Endorphins
  • Enkephalins
  • Narcotic Antagonists
  • Narcotics
  • Receptors, Opioid
  • Naloxone
  • Ethylketocyclazocine
  • Quinuclidinyl Benzilate
  • Morphine
  • endorphin, humoral
  • Sodium
  • Cyclazocine